We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current BIOG market cap is 385.66M. The company's latest EPS is GBP -1.0034 and P/E is -9.34.
| Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 29.04M | 68.94M | 225.51M | -194.22M | -32.42M |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | 21.1M | 60.9M | 200.43M | -202.42M | -41.3M |
| Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 431.23M | 401.19M | 649.53M | 427.45M | 360.51M |
| Total Liabilities | 22.36M | 35.62M | 48.07M | 33.24M | 30.22M |
| Total Equity | 408.88M | 365.57M | 601.47M | 394.21M | 330.29M |
| Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -4.4M | -3.77M | -5.67M | -12.14M | -5.89M |
| Investing | 45.8M | 90.93M | -25.55M | 13.03M | 45.69M |
| Financing | -41.4M | -87.17M | 32.73M | -2.39M | -37.03M |
| Market Cap | 385.66M |
| Price to Earnings Ratio | -9.34 |
| Price to Sales Ratio | -11.9 |
| Price to Cash Ratio | 139.23 |
| Price to Book Ratio | 1.17 |
| Dividend Yield | - |
| Shares Outstanding | 41.16M |
| Average Volume (1 week) | 51.73k |
| Average Volume (1 Month) | 70.5k |
| 52 Week Change | 18.61% |
| 52 Week High | 1,034.00 |
| 52 Week Low | 715.00 |
| Spread (Intraday) | 8 (0.85%) |
| Company Name | Biotech Growth Trust (the) Plc |
| Address |
one wood street london EC2V 7WS |
| Website | https://www.biotechgt.com |
| Industry | unit inv tr, closed-end mgmt (6726) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
